Literature DB >> 20878714

Computational studies of the interaction between the HIV-1 integrase tetramer and the cofactor LEDGF/p75: insights from molecular dynamics simulations and the informational spectrum method.

Cristina Tintori1, Nevena Veljkovic, Veljko Veljkovic, Maurizio Botta.   

Abstract

A crystal structure of the integrase binding domain (IBD) of the lens epithelium-derived growth factor (LEDGF/p75) in complex with the dimer of the HIV-1 integrase (IN) catalytic core domain (CCD) provides useful information that might help in the understanding of essential protein-protein contacts in HIV-1. However, mutagenic studies indicated that interactions between the full-length proteins were more extensive than the contacts observed in the co-crystal structure of the isolated domains. On the other hand, the biochemical characterization of the interaction between full-length IN and LEDGF/p75 has recently proved that LEDGF/p75 promotes IN tetramerization with two LEDGF/p75 IBD molecules bound to the IN tetramer. This experimental evidence suggests that to obtain a complete structural description of the interactions between the two proteins, the full-length tetrameric structure of IN should be considered. Our aim was to obtain a detailed picture of HIV-1 IN interactions with cellular co-factors that was of general interest, particularly for the development of small molecule IN inhibitors, which mimic the IBD of LEDGF/p75. To this end, we performed bioinformatics analyses to identify protein sequence domains involved in long-range recognition. Subsequently, we applied molecular dynamics techniques to investigate the detailed interactions between the complete tetrameric form of IN and two molecules of the IBD of LEDGF/p75. Our dynamic picture is in agreement with experimental data and, thereby, provides new details of the IN-LEDGF/p75 interaction.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878714     DOI: 10.1002/prot.22847

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  4 in total

1.  2-Aminothiazolones as anti-HIV agents that act as gp120-CD4 inhibitors.

Authors:  Marika Tiberi; Cristina Tintori; Elisa Rita Ceresola; Roberta Fazi; Claudio Zamperini; Pierpaolo Calandro; Luigi Franchi; Manikandan Selvaraj; Lorenzo Botta; Michela Sampaolo; Diego Saita; Roberto Ferrarese; Massimo Clementi; Filippo Canducci; Maurizio Botta
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

2.  In silico analysis suggests interaction between Ebola virus and the extracellular matrix.

Authors:  Veljko Veljkovic; Sanja Glisic; Claude P Muller; Matthew Scotch; Donald R Branch; Vladimir R Perovic; Milan Sencanski; Nevena Veljkovic; Alfonso Colombatti
Journal:  Front Microbiol       Date:  2015-02-19       Impact factor: 5.640

3.  Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection.

Authors:  Veljko Veljkovic; Philippe M Loiseau; Bruno Figadere; Sanja Glisic; Nevena Veljkovic; Vladimir R Perovic; David P Cavanaugh; Donald R Branch
Journal:  F1000Res       Date:  2015-02-02

4.  Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.

Authors:  Weiwei Xue; Huanxiang Liu; Xiaojun Yao
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.